Identification of a high-affinity phosphopeptide inhibitor of Stat3

Stat3 is a latent transcription factor that exhibits elevated activity in a variety of human cancers. To find a lead peptide for peptidomimetic drug development we synthesized and tested phosphopeptides derived from known receptor docking sites and found Y(p)LPQTV as the optimal sequence, SAR studies showed that each residue from pY to pY + 3 provided binding energy. (C) 2003 Elsevier Science Ltd. All rights reserved.